terican

Last verified · v1.0

Calculator · health

Timi Risk Score For Stemi Calculator

TIMI STEMI calculator predicts 30-day mortality in ST-elevation MI using 8 validated clinical variables including age, Killip class, and hemodynamics.

FreeInstantNo signupOpen source

Inputs

30-Day Mortality Risk

—

Explain my result

0/3 free

Get a plain-English breakdown of your result with practical next steps.

30-Day Mortality Risk—

The formula

How the
result is
computed.

What Is the TIMI Risk Score for STEMI?

The Thrombolysis in Myocardial Infarction (TIMI) Risk Score for ST-Elevation Myocardial Infarction (STEMI) is a validated, eight-variable clinical tool that predicts 30-day all-cause mortality in STEMI patients. Originally derived by Morrow et al. from over 14,000 patients enrolled in the InTIME II fibrinolytic trial, the score translates easily measurable clinical parameters at the bedside into a single integer that stratifies mortality risk at the time of presentation. Emergency physicians and cardiologists rely on the TIMI STEMI calculator to prioritize interventions, allocate catheterization laboratory resources, and communicate prognostic expectations to patients and families.

The TIMI STEMI Formula

The composite score equals the sum of eight independent mortality predictors, each assessed at the time of initial presentation:

  • Age: Patients aged 75 years or older receive 3 points; those aged 65 to 74 receive 2 points; patients under 65 receive 0 points.
  • History of Diabetes, Hypertension, or Angina: A documented history of any one of these three conditions adds 1 point.
  • Systolic Blood Pressure below 100 mmHg: Hemodynamic compromise at presentation contributes 3 points, the highest single-variable weight in the entire score.
  • Heart Rate above 100 bpm: Tachycardia on presentation adds 2 points.
  • Killip Class II through IV: Any degree of clinical heart failure including crackles, S3 gallop, pulmonary edema, or cardiogenic shock adds 2 points.
  • Body Weight below 67 kg: Low body weight, a surrogate for frailty and reduced physiologic reserve, adds 1 point.
  • Anterior ST-Elevation or New Left Bundle Branch Block (LBBB): These ECG findings indicate a larger myocardial territory at risk and add 1 point.
  • Time to Treatment Exceeding 4 Hours: Delayed reperfusion beyond 4 hours from symptom onset adds 1 point.

The maximum achievable score is 14 points.

Risk Stratification by Score

Higher TIMI STEMI scores correlate with exponentially increasing 30-day all-cause mortality. The following risk bands, derived from the original InTIME II trial analysis, guide clinical interpretation:

  • Score 0 to 3 (Low Risk): Approximately 1 to 4% 30-day mortality.
  • Score 4 to 6 (Moderate Risk): Approximately 7 to 16% 30-day mortality.
  • Score 7 to 9 (High Risk): Approximately 23 to 27% 30-day mortality.
  • Score 10 to 14 (Very High Risk): 30-day mortality exceeding 35%.

Key Clinical Variables Explained

Age Weighting

Advanced age is the strongest demographic predictor of STEMI mortality. The score assigns 3 points for age 75 or older because elderly patients face heightened risk from both myocardial damage and from reperfusion therapy complications, including major bleeding events associated with systemic fibrinolysis.

Killip Classification

The Killip classification quantifies acute heart failure severity at bedside. Class I denotes no clinical heart failure; Class II includes mild failure such as an S3 gallop or bibasilar rales; Class III represents frank pulmonary edema; Class IV indicates cardiogenic shock with systemic hypoperfusion. Any Killip class from II through IV signals impaired cardiac output and substantially worsens short-term prognosis.

Systolic Blood Pressure

Systolic hypotension below 100 mmHg is the highest-weighted single variable at 3 points because it signals either extensive myocardial necrosis or early cardiogenic shock. Both conditions dramatically increase in-hospital and 30-day mortality and demand urgent escalation of care.

Worked Clinical Example

A 70-year-old female (2 pts) with documented hypertension (1 pt) presents with an anterior STEMI confirmed on ECG (1 pt) five hours after symptom onset (1 pt). Her presenting heart rate is 112 bpm (2 pts), systolic BP is 88 mmHg (3 pts), Killip Class II on auscultation (2 pts), and body weight is 60 kg (1 pt). TIMI Score = 2+1+1+1+2+3+2+1 = 13 points, placing her in the very high-risk category with estimated 30-day mortality exceeding 35% and indicating the need for immediate aggressive reperfusion and hemodynamic support.

Validated Sources and Methodology

The TIMI Risk Score for STEMI has been validated across multiple large-scale registries and randomized controlled trials. A 2023 peer-reviewed analysis confirmed its discriminatory power for in-hospital mortality in STEMI populations (Validity of TIMI Risk Score and HEART Score for Risk Assessment, PMC 2023). Comparative research against the GRACE risk score, published in academic literature (Comparison of Prognostic Value of TIMI and GRACE Risk Scores in Acute Coronary Syndrome), found that the TIMI STEMI score performs particularly well in fibrinolysis-treated STEMI cohorts. Clinicians should always interpret the score alongside dynamic clinical findings, serial ECG data, cardiac biomarker trends, and institutional STEMI protocol guidelines rather than relying on the score in isolation.

Reference

Frequently asked questions

What is the TIMI risk score for STEMI and why is it used?
The TIMI risk score for STEMI is a validated eight-variable clinical scoring tool that predicts 30-day all-cause mortality in patients presenting with ST-elevation myocardial infarction. Scores range from 0 to 14 points, with higher scores indicating exponentially greater mortality risk. A score of 0 to 3 carries approximately 1 to 4% mortality, while scores above 10 exceed 35%, helping clinicians rapidly stratify care intensity.
How is the TIMI STEMI score calculated step by step?
The TIMI STEMI score is calculated by summing eight variables: age scored as 0, 2, or 3 points; history of diabetes, hypertension, or angina worth 1 point; systolic BP below 100 mmHg worth 3 points; heart rate above 100 bpm worth 2 points; Killip Class II to IV worth 2 points; weight below 67 kg worth 1 point; anterior ST-elevation or new LBBB worth 1 point; and time to treatment exceeding 4 hours worth 1 point. The maximum total is 14 points.
What does a TIMI STEMI score of 7 or higher indicate?
A TIMI STEMI score of 7 or higher places a patient in the high-risk category, corresponding to an estimated 30-day all-cause mortality of approximately 23% or greater. Scores of 10 or above indicate very high risk with mortality exceeding 35%. These patients typically require immediate aggressive reperfusion therapy, intensive hemodynamic monitoring, and early consideration of mechanical circulatory support devices if hemodynamic instability is present or develops.
How does the TIMI STEMI calculator differ from the TIMI risk score for NSTEMI or unstable angina?
The TIMI risk score for STEMI and the TIMI risk score for NSTEMI and unstable angina are entirely distinct tools developed from different patient populations and endpoints. The STEMI version uses eight variables including Killip class, systolic blood pressure, and time to treatment to predict 30-day mortality. The NSTEMI version uses seven different variables, including ST deviation and prior coronary stenosis, to predict 14-day risk of death, MI, or urgent revascularization. The two scores are not interchangeable clinically.
What are the main limitations of the TIMI risk score for STEMI?
The TIMI STEMI score carries several important limitations. It was derived from the InTIME II fibrinolysis trial population, which may reduce generalizability to primary PCI-treated patients. The score omits cardiac biomarker data such as troponin levels. It treats Killip classification as a binary variable rather than capturing severity gradations. The 67 kg body weight threshold may not uniformly reflect frailty across diverse populations, body habitus types, or geographic regions with differing baseline body mass distributions.
Can the TIMI STEMI score guide the choice between fibrinolysis and primary PCI?
The TIMI STEMI score provides prognostic stratification but does not directly prescribe a specific reperfusion strategy. However, very high scores reflecting features such as cardiogenic shock, hypotension, and large anterior infarction often reinforce guideline-recommended preferences for primary PCI when it is available within appropriate time windows. Current ACC/AHA STEMI guidelines recommend primary PCI as the preferred reperfusion strategy when it can be performed within 120 minutes of first medical contact, regardless of TIMI score.